MedPath

Cervical Ripening in Obese Women: Efficacy of 25 mcg Versus 50 mcg of Misoprostol

Not Applicable
Conditions
Induction of Labor Affected Fetus / Newborn
Interventions
Registration Number
NCT03748147
Lead Sponsor
University of Cincinnati
Brief Summary

This is a prospective clinical trial to determine if 50 mcg versus 25 mcg po every four hours of misoprostol has improved efficacy and similar safety in obese women undergoing cesarean section.

Detailed Description

We will perform a prospective, randomized, double-blind clinical trial with parallel assignment.

Obese women (delivery BMI 30 or more) who agree to participation will be randomly designated to receive either 25 mcg po q 4 hour (control) misoprosol versus 50 mcg po q 4 hours. Our primary outcome will be the rate of successful induction. Secondary outcomes will include ability to achieve a Bishop score greater than 7, time to active labor, and safety data including rate of tachysystole, non-reassuring fetal status, NICU admission.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
300
Inclusion Criteria
  • Labor induction, BMI of 30 or greater, English speaking
Exclusion Criteria
  • Prior cesarean section, uterine tachysystole (5 contractions/ 10 minutes) on admission, Contraindication to labor induction

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
InterventionMisoprostolMisoprostol 50 mcg po every four hours
ControlMisoprostolStandard of care, misoprostol 25 mcg po every four hours
Primary Outcome Measures
NameTimeMethod
Vaginal deliveryVariable, but within 4 days

Successful induction defined as a vaginal delivery following labor induction.

Secondary Outcome Measures
NameTimeMethod
Completed cervical ripening2 days

Bishop score of greater than 7 (Bishop score designated per protocol based upon cervical dilation, effacement, station, consistency and position).

Rate of tachysystole, fetal nonreassuring status, uterine rupture3 days

Rate of the following as categorical variables: tachysystole (any delay in study medication administration for greater than 5 contractions/10 minute window), non-reassuring fetal status (any evaluation of the fetal tracing that leads to delays in study drug administration secondary to concerns for the fetal status), NICU admission, uterine rupture

Specific time interval from start of induction to active labor2 days

We will measure the interval (hours) between start of cervical ripening and active labor defined as reaching a cervical dilation of 6 cm.

© Copyright 2025. All Rights Reserved by MedPath